AZ Phoenix의 전이성 암 임상 시험
전이성 암 관련 연구 20개가 Phoenix 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
피험자 모집 중3상
- City of Hope, Phoenix
PRE-ISPY Phase I/II Oncology Platform Program
피험자 모집 중1/2상
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
피험자 모집 중2/3상
- Mayo Clinic Hospital, Phoenix
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Banner MD Anderson Cancer Center, Phoenix
- Ironwood Cancer & Research Centers, Phoenix
- Mayo Clinic Building- Phoenix, Phoenix
- 외 1개
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
피험자 모집 중1상
- Mayo Clinic Arizona, Phoenix
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Ironwood Cancer & Research Centers, Phoenix
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
피험자 모집 중2/3상
- Mayo Clinic Hospital, Phoenix
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- Mayo Clinic Building-Phoenix, Phoenix
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- Mayo Clinic in Arizona - Phoenix, Phoenix
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- HonorHealth, Phoenix
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
피험자 모집 중2상
- Mayo Clinic Arizona, Phoenix
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
피험자 모집 중1/2상
- Mayo Clinic Building- Phoenix, Phoenix
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- Banner University Medical Center Phoenix, Phoenix
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Mayo Clinic, Phoenix
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
피험자 모집 중1/2상
- Crinetics Study Site, Phoenix
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Investigative Site #132, Phoenix
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
피험자 모집 중
- Dignity Health, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
피험자 모집 중관찰 연구
- Mayo Clinic in Arizona, Phoenix
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
피험자 모집 중1/2상
- Mayo Clinic, Phoenix
다른 도시의 전이성 암 시험
- Houston, TX연구 104개
- New York City, NY연구 93개
- Nashville, TN연구 70개
- Boston, MA연구 63개
- Los Angeles, CA연구 57개
- St. Louis, MO연구 54개
- Arlington, VA연구 53개
- Philadelphia, PA연구 46개
- Chicago, IL연구 45개
- San Antonio, TX연구 44개
- Washington, DC연구 43개
- Dallas, TX연구 42개
Phoenix의 다른 연구
- 유방암연구 25개
- 대장직장암연구 25개
- 비만연구 22개
- 비소세포폐암연구 20개
- 심부전연구 18개
- 전립선암연구 17개
- 암 (전체)연구 17개
- 다발성 골수종연구 16개
- 췌장암연구 16개
- 심혈관 질환연구 16개
- 알츠하이머병연구 15개
- 과체중연구 15개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.